title: Pulmonary rehabilitation in chronic respiratory diseases--from goals to outcomes.
abstract: This paper is a review of current approaches on pulmonary rehabilitation (PR) in chronic pulmonary diseases. Pulmonary rehabilitation is the most accepted method of non-pharmacological treatment in patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, bronchiectasis, cystic fibrosis, interstitial lung disease, neuromuscular degenerative disease and post-tuberculosis lung sequelae. Throughout its components, especially oxygen therapy, it is the most important intervention in chronic respiratory failure in order to improve exercise tolerance, lung function and self-management. Enrolling patients in pulmonary rehabilitation programmes is a consistent help to a better control of their illness and a step forward to the international standards of treating COPD and non-COPD chronic respiratory diseases. It is evidence-based that PR is effective in reducing dyspnoea, improving health-related quality of life, reducing the number of hospital days and the utilisation of costly healthcare resources; there are also psychosocial benefits from comprehensive PR programmes in patients with COPD. PR is currently considered as effective in patients with COPD and in some patients with chronic respiratory diseases other than COPD.
authors.affiliation: University of Belgrade School of Medicine, Institute of Lung Diseases and Tuberculosis, Research and Epidemiology Department, Belgrade, Serbia. dppesut@verat.net
authors.forename: Dragica
authors.initials: D
authors.lastname: Pesut
authors.forename: Laura
authors.initials: L
authors.lastname: Ciobanu
authors.forename: Ljudmila
authors.initials: L
authors.lastname: Nagorni-Obradovic
mesh_terms: D001249:Asthma / Q000534:rehabilitation; D001987:Bronchiectasis / Q000534:rehabilitation; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000534:rehabilitation; D004417:Dyspnea / Q000209:etiology / Q000628:therapy; D005081:Exercise Therapy; D017048:Health Care Costs; D006801:Humans; D008171:Lung Diseases / Q000150:complications / Q000191:economics / Q000534:rehabilitation*; D017563:Lung Diseases, Interstitial / Q000534:rehabilitation; D009468:Neuromuscular Diseases / Q000534:rehabilitation; D010102:Oxygen Inhalation Therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000534:rehabilitation; D011788:Quality of Life; D014397:Tuberculosis, Pulmonary / Q000534:rehabilitation